Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Line Items]
Provision for income taxes	$ 0	$ 0
Net operating loss carryforwards	17,548,951	12,059,019
Research and development and orphan drug credits	$ 9,400,000
Net operating loss carryforwards term	20 years
Net operating loss carryforwards expiration beginning year	2031
Uncertain tax positions, accruals	$ 0	0
Accruals for interest or penalties related to income tax matters	0	$ 0
Gross deferred tax asset	$ 19,000,000.0
Research and Development Credits
Income Tax Disclosure [Line Items]
Tax credit carryforwards expiration beginning year	2032
Orphan Drug Credits
Income Tax Disclosure [Line Items]
Tax credit carryforwards expiration beginning year	2034
U.S. Federal
Income Tax Disclosure [Line Items]
Net operating loss carryforwards	$ 66,600,000
State
Income Tax Disclosure [Line Items]
Net operating loss carryforwards	65,600,000
Research and development credits	$ 67,000